Similarly, overexpression of the same nonphosphorylatable HSP27 mutant with gemcitabine, a DNA replication–targeted chemotherapy treatment in pancreatic cancer cells, decreased cell proliferation (164, 167). The gene discussed is HSPB3; the disease is pancreatic neoplasm.